spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  COX-2 inhibitor 

 HSMN NewsFeed - 3 Jan 2018
Recro Pharma Announces Key Executive Promotions to the Financial Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2017
Noden Pharma Announces FDA Approval of Tekturna(R) (aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 6 Mar 2017
Recro Pharma Appoints Bryan Reasons to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jul 2016
Recro Pharma Appoints Michael Celano as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Feb 2016
Recro Pharma Appoints Fred Graff as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Oct 2015
Recro Pharma Provides Pipeline Update
Biopharmaceuticals
 HSMN NewsFeed - 27 Jan 2015
Euclises Announces Appointment of Bobby Sandage as New CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 May 2010
NicOx provides update on FDA Advisory Committee Meeting for naproxcinod
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Jan 2010
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Dec 2009
Roche Licenses First-in-Class Treatments for Chronic Pain to Afferent Pharmaceuticals; Afferent Secures $23 Million in Series A Financing
Biopharmaceuticals Licensing Venture Capital
 HSMN NewsFeed - 12 Nov 2009
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 6 Oct 2009
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Aug 2008
Biovail Receives Canadian Approval for Ralivia(TM) for the Treatment of Moderately Severe Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2008
Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
Biopharmaceuticals
 HSMN NewsFeed - 10 Mar 2008
Labopharm Initiates Phase III Clinical Trial for Twice-Daily Formulation of Tramadol-Acetaminophen
Biopharmaceuticals
 HSMN NewsFeed - 7 Feb 2008
Transdel Pharmaceuticals Submits to the FDA the Phase 3 Clinical Study of Ketotransdel(TM) for the Treatment of Acute Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Jan 2008
Mersana Therapeutics, Inc. Appoints John H. van Duzer, Ph.D., as Vice President of Manufacturing and Pharmaceutical Sciences
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
Biovail Launches Ralivia(TM) to Canadian Physicians
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 10 Oct 2007
Anesiva Defines Regulatory Pathway for Adlea with FDA
Biopharmaceuticals Surgery
 HSMN NewsFeed - 17 Sep 2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada
Biopharmaceuticals
 HSMN NewsFeed - 14 Aug 2007
BDSI Names David Blum, M.D. Vice President of Medical Affairs and Clinical Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jul 2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 2 Jul 2007
NicOx appoints Pascal Pfister MD as Chief Scientific Officer and strengthens R&D organization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jun 2007
Genzyme Files for Approval of Single-Treatment Synvisc-One(TM)
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Jun 2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Apr 2007
Merck Receives Non Approvable Letter from FDA for ARCOXIA(R) (etoricoxib)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Apr 2007
FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA(R) (etoricoxib)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Feb 2007
American Heart Association Scientific Statement: AHA Statement Recommends Doctors Change Approach to Prescribing Pain Relievers for Patients With or at Risk for Heart Disease
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 8 Jan 2007
Horizon Therapeutics Announces Special Protocol Assessment With FDA for Phase 3 Trial Program
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
Merck Remains Confident in Future Growth as it Executes on New Strategy
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2006
Large Outcomes Study Showed Merck's ARCOXIA(R) (etoricoxib) had Similar Rates of Cardiovascular Thrombotic Events Compared to Diclofenac, the Most Prescribed Traditional NSAID Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 10 Nov 2006
Merck Responds to FDA-Issued Approvable Letters for Arcoxia(R) (etoricoxib)
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Oct 2006
DOV Pharmaceutical, Inc. Announces New Strategic Direction, Bicifadine Clinical Studies Results and Program Updates
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2006
Genzyme Receives European Approval for Synvisc(R) In Ankle and Shoulder Osteoarthritis Indications
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 23 Jun 2006
Positive Synvisc Data Presented at European Conference
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 44

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 44 additional stories matching:
COX-2 inhibitor
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!